Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced. A randomized intervention study

American Journal of Hypertension

Volumn 11, Issue 1, 1998, Pages 14-22

  Fagerberg, Björn ^a   Wikstrand, John ^b   Berglund, Göran ^c   Samuelsson, Ola ^a   Agewall, Stefan ^a   Andersson, Ove K ^d   Hartford, Marianne ^d   Hedner, Thomas ^d   Herlitz, Hans ^d   Ljungman, Susanne ^d   Persson, Bengt ^d   Widgren, Bengt ^d   Wysocki, Marian ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Department of Medicine Malmö University Hospital Lund University ^*

Author keywords

Diabetes mellitus; Hypercholesterolemia; Hypertension; Mortality; Smoking

Indexed keywords

CHOLESTEROL; COLESTYRAMINE; COTININE; FIBRIC ACID DERIVATIVE; LIPID; NICOTINIC ACID; STATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOKING; SMOKING CESSATION;

EID: 0031920092     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00363-4     Document Type: Article

References (31)

1. Wilhelmsen L, Wedel H, Tibblin G: Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-958.
2. Kannel WB, Sorlie P: Hypertension in Framingham, in Paul O (ed): Epidemiology and Control of Hypertension. Georg Thieme Verlag, Stuttgart, 1975, pp 553-590.
3. Zanchetti A, Chalmers JP, Arakawa K, et al: The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Pressure 1993:2:86-100.
4. Hjermann I, Velve Byre K, Holme I, Leren P: Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981;ii:1303-1310.
5. Kornitzer M, DeBacker G, Dramaix M, et al: Belgian heart disease prevention project: incidence and mortality results. Lancet 1983;i:1066-1070.
6. World Health Organization European Collaborative Group: European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year-results. Lancet 1986;i:869-872.
7. Multiple Risk Factor Intervention Trial Research Group: Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982: 248:1465-1477.
8. Wilhelmsen L, Berglund G, Elmfeldt D, et al: The multifactorial primary prevention trial in Gothenburg, Sweden. Eur Heart J 1986;7:279-288.
9. Strandberg T, Salomaa VV, Naukkarinen VA, et al: Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991;266:1225-1229.
10. Andersson O, Berglund G, Hansson L et al: Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand 1978;203:391-398.
11. Samuelsson O: Hypertension in middle-aged men: management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand 1985; 702(suppl):1-79.
12. Samuelsson O, Wilhelmsen L, Andersson OK, et al: Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. JAMA 1987;258:1768-1776.
13. Agewall S, Fagerberg B, Samuelsson O, et al. Multiple cardiovascular risk factor intervention in treated hypertensive men: what can be achieved. Nutr Metab Cardiovasc Dis 1993;3:128-135.
14. Agewall S, Wikstrand J, Samuelsson O, et al: The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. J Intern Med 1994;236:651-659.
15. Klose S, Borner K: Enzymatische bestimmung des gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II). J Clin Chem Clin Biochem 1978;15:121-130.
16. Wikstrand J, Warnold I, Olsson G, et al: Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY Study. JAMA 1988; 259:1976-1982.
17. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, et al: Comparison of tests used to distinguish smokers from nonsmokers. Am J Publ Health 1987;77:1435-1438.
18. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988;148:36-69.
19. Drug Information Committee: Treatment of hyperlipidemia. Uppsala, Sweden: National Board of Health and Welfare, Drug Information Committee, 1989.
20. Keys A (ed): Coronary heart disease in seven countries. Circulation 1970;41(suppl I):I-1-I-19.
21. Rose GA, Blackburn H: Classification of the electrocardiogram for population studies, in Cardiovascular Survey Methods. World Health Organization Monograph Series No. 56. World Health Organization, Geneva, 1968, pp 137-154.
22. Agewall S, Wikstrand J, Dahlöf C, Fagerberg B: A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk. J Hypertens 1995;13:1471-1477.
23. Reaven GM, Lithell H, Landsberg L. Hypertension and associated abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381.
24. Samuelsson O, Hedner T, Berglund G, et al: Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. J Human Hypertens 1994; 8:257-263.
25. Ramsay LE, Yeo WW, Jackson PR: Dietary reduction of serum cholesterol concentration: time to think again. Br Med J 1991;303:953-957.
26. Fagerberg B, Wiklund O, Agewall S, et al: Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans. Eur J Clin Invest 1996;26:960-965.
27. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherosclerosis. Arterioscl Thromb 1995;15:551-561.
28. Gould AL, Rossouw JE, Santanello NC, et al: Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 1995;91:2274-2282.
29. You RS, Donnan GA: Serum risk factors for stroke. Cardiovasc Risk Fact 1995;5:348-362.
30. The Scandinavian Simvastatin Survival Study group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
31. Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009.